vs
Acadia Healthcare Company, Inc.（ACHC）与美泰（MAT）财务数据对比。点击上方公司名可切换其他公司
美泰的季度营收约是Acadia Healthcare Company, Inc.的1.0倍（$862.2M vs $829.0M），美泰净利率更高（7.1% vs 0.5%，领先6.5%），Acadia Healthcare Company, Inc.同比增速更快（7.5% vs 4.3%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -10.6%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
美泰是美国知名玩具及娱乐企业，旗下影视制作部门美泰影业运营时间为2018年9月6日至2025年6月2日。其前身为2013年10月16日成立的美泰Playground Productions，更早可追溯至美泰娱乐、美泰工作室等集团原有娱乐业务品牌。
ACHC vs MAT — 直观对比
营收规模更大
MAT
是对方的1.0倍
$829.0M
营收增速更快
ACHC
高出3.2%
4.3%
净利率更高
MAT
高出6.5%
0.5%
两年增速更快
ACHC
近两年复合增速
-10.6%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $862.2M |
| 净利润 | $4.5M | $61.0M |
| 毛利率 | — | 44.9% |
| 营业利润率 | — | — |
| 净利率 | 0.5% | 7.1% |
| 营收同比 | 7.5% | 4.3% |
| 净利润同比 | -50.8% | 251.4% |
| 每股收益（稀释后） | $0.05 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCMAT
| Q1 26 | $829.0M | $862.2M | ||
| Q4 25 | $821.5M | $1.8B | ||
| Q3 25 | $851.6M | $1.7B | ||
| Q2 25 | $869.2M | $1.0B | ||
| Q1 25 | $770.5M | $826.6M | ||
| Q4 24 | $774.2M | $1.6B | ||
| Q3 24 | $815.6M | $1.8B | ||
| Q2 24 | $796.0M | $1.1B |
净利润ACHCMAT
| Q1 26 | $4.5M | $61.0M | ||
| Q4 25 | $-1.2B | $106.2M | ||
| Q3 25 | $36.2M | $278.4M | ||
| Q2 25 | $30.1M | $53.4M | ||
| Q1 25 | $8.4M | $-40.3M | ||
| Q4 24 | $32.6M | $140.9M | ||
| Q3 24 | $68.1M | $372.4M | ||
| Q2 24 | $78.5M | $56.9M |
毛利率ACHCMAT
| Q1 26 | — | 44.9% | ||
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 50.0% | ||
| Q2 25 | — | 50.9% | ||
| Q1 25 | — | 49.4% | ||
| Q4 24 | — | 50.7% | ||
| Q3 24 | — | 53.1% | ||
| Q2 24 | — | 49.2% |
营业利润率ACHCMAT
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 8.0% | ||
| Q3 25 | 4.7% | 21.9% | ||
| Q2 25 | 5.8% | 7.7% | ||
| Q1 25 | 1.7% | -6.4% | ||
| Q4 24 | 4.9% | 9.6% | ||
| Q3 24 | 12.1% | 26.5% | ||
| Q2 24 | 13.4% | 7.7% |
净利率ACHCMAT
| Q1 26 | 0.5% | 7.1% | ||
| Q4 25 | -143.3% | 6.0% | ||
| Q3 25 | 4.3% | 16.0% | ||
| Q2 25 | 3.5% | 5.2% | ||
| Q1 25 | 1.1% | -4.9% | ||
| Q4 24 | 4.2% | 8.6% | ||
| Q3 24 | 8.4% | 20.2% | ||
| Q2 24 | 9.9% | 5.3% |
每股收益（稀释后）ACHCMAT
| Q1 26 | $0.05 | $0.20 | ||
| Q4 25 | $-12.98 | $0.32 | ||
| Q3 25 | $0.40 | $0.88 | ||
| Q2 25 | $0.33 | $0.16 | ||
| Q1 25 | $0.09 | $-0.12 | ||
| Q4 24 | $0.36 | $0.40 | ||
| Q3 24 | $0.74 | $1.09 | ||
| Q2 24 | $0.85 | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $866.0M |
| 总债务越低越好 | $2.5B | $2.3B |
| 股东权益账面价值 | $2.0B | $2.1B |
| 总资产 | $5.5B | $6.3B |
| 负债/权益比越低杠杆越低 | 1.29× | 1.11× |
8季度趋势，按日历期对齐
现金及短期投资ACHCMAT
| Q1 26 | $158.5M | $866.0M | ||
| Q4 25 | $133.2M | $1.2B | ||
| Q3 25 | $118.7M | $691.9M | ||
| Q2 25 | $131.4M | $870.5M | ||
| Q1 25 | $91.2M | $1.2B | ||
| Q4 24 | $76.3M | $1.4B | ||
| Q3 24 | $82.1M | $723.5M | ||
| Q2 24 | $77.2M | $722.4M |
总债务ACHCMAT
| Q1 26 | $2.5B | $2.3B | ||
| Q4 25 | $2.5B | $2.3B | ||
| Q3 25 | $2.3B | $2.3B | ||
| Q2 25 | $2.3B | $2.3B | ||
| Q1 25 | $2.2B | $2.3B | ||
| Q4 24 | $2.0B | $2.3B | ||
| Q3 24 | $1.9B | $2.3B | ||
| Q2 24 | $1.8B | $2.3B |
股东权益ACHCMAT
| Q1 26 | $2.0B | $2.1B | ||
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $3.1B | $2.3B | ||
| Q2 25 | $3.1B | $2.2B | ||
| Q1 25 | $3.0B | $2.1B | ||
| Q4 24 | $3.1B | $2.3B | ||
| Q3 24 | $3.0B | $2.3B | ||
| Q2 24 | $3.0B | $2.0B |
总资产ACHCMAT
| Q1 26 | $5.5B | $6.3B | ||
| Q4 25 | $5.5B | $6.6B | ||
| Q3 25 | $6.4B | $6.6B | ||
| Q2 25 | $6.3B | $6.2B | ||
| Q1 25 | $6.1B | $6.2B | ||
| Q4 24 | $6.0B | $6.5B | ||
| Q3 24 | $5.9B | $6.5B | ||
| Q2 24 | $5.7B | $5.9B |
负债/权益比ACHCMAT
| Q1 26 | 1.29× | 1.11× | ||
| Q4 25 | 1.28× | 1.04× | ||
| Q3 25 | 0.74× | 1.03× | ||
| Q2 25 | 0.74× | 1.08× | ||
| Q1 25 | 0.72× | 1.10× | ||
| Q4 24 | 0.64× | 1.03× | ||
| Q3 24 | 0.62× | 1.01× | ||
| Q2 24 | 0.62× | 1.18× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | $-88.1M |
| 自由现金流率自由现金流/营收 | — | -10.2% |
| 资本支出强度资本支出/营收 | — | 7.6% |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCMAT
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $796.6M | ||
| Q3 25 | $73.2M | $72.0M | ||
| Q2 25 | $133.5M | $-300.1M | ||
| Q1 25 | $11.5M | $24.8M | ||
| Q4 24 | $116.7M | $862.1M | ||
| Q3 24 | $163.1M | $155.8M | ||
| Q2 24 | $171.1M | $-252.9M |
自由现金流ACHCMAT
| Q1 26 | — | $-88.1M | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — |
自由现金流率ACHCMAT
| Q1 26 | — | -10.2% | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — |
资本支出强度ACHCMAT
| Q1 26 | — | 7.6% | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — |
现金转化率ACHCMAT
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 7.50× | ||
| Q3 25 | 2.02× | 0.26× | ||
| Q2 25 | 4.43× | -5.62× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 6.12× | ||
| Q3 24 | 2.39× | 0.42× | ||
| Q2 24 | 2.18× | -4.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
MAT
暂无分部数据
